RPAM
Rhenman & Partners Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Sell |
344,000
-67,000
| -16% | -$2.41M | 1.57% | 25 |
|
|
2025
Q1 | $12.8M | Sell |
411,000
-184,000
| -31% | -$5.73M | 1.47% | 28 |
|
|
2024
Q4 | $15.2M | Sell |
595,000
-18,500
| -3% | -$472K | 1.56% | 23 |
|
|
2024
Q3 | $17.4M | Buy |
613,500
+68,803
| +13% | +$1.95M | 1.41% | 24 |
|
|
2024
Q2 | $14.4M | Hold |
544,697
| – | – | 1.38% | 25 |
|
|
2024
Q1 | $16.5M | Buy |
544,697
+115,000
| +27% | +$3.49M | 1.57% | 25 |
|
|
2023
Q4 | $12.1M | Buy |
429,697
+279,697
| +186% | +$7.86M | 1.21% | 32 |
|
|
2023
Q3 | $4.07M | Hold |
150,000
| – | – | 0.44% | 58 |
|
|
2023
Q2 | $4.61M | Sell |
150,000
-15,000
| -9% | -$461K | 0.49% | 58 |
|
|
2023
Q1 | $5.99M | Sell |
165,000
-50,000
| -23% | -$1.82M | 0.66% | 51 |
|
|
2022
Q4 | $8.5M | Hold |
215,000
| – | – | 0.89% | 43 |
|
|
2022
Q3 | $9.1M | Buy |
215,000
+65,000
| +43% | +$2.75M | 0.95% | 40 |
|
|
2022
Q2 | $6.31M | Buy |
+150,000
| New | +$6.31M | 0.72% | 47 |
|
|
2021
Q2 | – | Sell |
-130,000
| Closed | -$5.67M | – | 98 |
|
|
2021
Q1 | $5.67M | Sell |
130,000
-120,000
| -48% | -$5.23M | 0.4% | 70 |
|
|
2020
Q4 | $12.5M | Buy |
+250,000
| New | +$12.5M | 1.02% | 43 |
|